|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2200065215 |
|
最近更新日期: Date of Last Refreshed on: |
2022-10-31 23:26:57 |
|
注册时间: Date of Registration: |
2022-10-31 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
食物过敏高风险婴儿使用匙倍乐的多中心前瞻性队列研究 |
|
Public title: |
A Multicenter Prospective Cohort Study using Spoonfulone Among High-Risk Infants for Food Allergy |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
食物过敏高风险婴儿使用匙倍乐的多中心前瞻性队列研究 |
|
Scientific title: |
A Multicenter Prospective Cohort Study using Spoonfulone Among High-Risk Infants for Food Allergy |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
刘亚南 |
研究负责人: |
赵冬梅 |
|
Applicant: |
Yanan Liu |
Study leader: |
Dongmei Zhao |
|
申请注册联系人电话: Applicant telephone: |
+8615554115341 |
研究负责人电话:
Study leader's |
+8613625419190 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
15554115341@163.com |
研究负责人电子邮件: Study leader's E-mail: |
jnzhaodongmei@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
山东省济南市槐荫区经十路23976号 |
研究负责人通讯地址: |
山东省济南市槐荫区经十路23976号 |
|
Applicant address: |
23976 Jingshi Road, Huaiyin District, Jinan City, Shandong Province |
Study leader's address: |
23976 Jingshi Road, Huaiyin District, Jinan City, Shandong Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
济南市儿童医院 |
||
|
Applicant's institution: |
Jinan Children's Hospital |
||
|
研究负责人所在单位: |
济南市儿童医院 |
||
|
Affiliation of the Leader: |
Jinan Children's Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
SDFE-IRB/P-2022001 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
济南市儿童医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Jinan Children's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-01-25 00:00:00 | ||
|
伦理委员会联系人: |
张乐海 |
||
|
Contact Name of the ethic committee: |
Lehai Zhang |
||
|
伦理委员会联系地址: |
山东省济南市槐荫区经十路23976号济南市儿童医院三楼伦理委员会办公室 |
||
|
Contact Address of the ethic committee: |
Office of Ethics Committee, 3rd Floor, Jinan Children's Hospital, 23976 Jingshi Road, Huaiyin District, Jinan City, Shandong Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+8615715313793 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
济南市儿童医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Jinan Children's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
山东省济南市槐荫区经十路23976号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
23976 Jingshi Road, Huaiyin District, Jinan City, Shandong Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
雀巢健康科学(中国)有限公司 |
||||||||||||||||||||||
|
Source(s) of funding: |
Nestlé Health Science China |
||||||||||||||||||||||
|
研究疾病: |
食物过敏 |
||||||||||||||||||||||
|
Target disease: |
Food allergy |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
析因分组(即根据危险因素或暴露因素分组) |
||||||||||||||||||||||
|
Study design: |
Factorial |
||||||||||||||||||||||
|
研究目的: |
评价匙倍乐在过敏高风险婴幼儿中使用的可行性和安全性,比较匙倍乐服用组和对照组对8大易致敏食物的耐受情况。 |
||||||||||||||||||||||
|
Objectives of Study: |
To compare the adverse events / allergic reactions and tolerance to predefined food groups of interest between the two groups and to assess the feasibility and safety of regular use of Spoonfulone among high-risk infants. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1) 经过敏风险量表筛查有过敏风险的婴儿; |
||||||||||||||||||||||
|
Inclusion criteria |
1)Infants at risk for allergies screened by the allergy risk scale; |
||||||||||||||||||||||
|
排除标准: |
1) 先天性畸形; |
||||||||||||||||||||||
|
Exclusion criteria: |
1) Congenital malformation; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-01-01 00:00:00至 To 2025-01-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-11-01 00:00:00 至 To 2023-11-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
非随机对照研究 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Non-randomized |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无(请阅读网站首页注册指南共享原始数据的方式内容) |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic Data Capture |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |